Author:
Ohmura T.,Tsunenari I.,Seidler R.,Chachin M.,Hayashi T.,Konomi A.,Matsumaru T.,Sumida T.,Hayashi N.,Horie Y.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference41 articles.
1. Remuzzi G, Schieppati A, Ruggenenti P (2002) Clinical practice. Nephropathy in patients with type 2 diabetes. N Engl J Med 346:1145–1151
2. Wolf G (1998) Molecular mechanisms of angiotensin II in the kidney: emerging role in the progression of renal disease. Nephrol Dial Transplant 13:1131–1142
3. Unger T, Cullman J, Gohlke P (1998) Clinical practice. Nephropathy in patients with type 2 diabetes. Angiotensin II receptor blockade and end-organ protection: pharmacological rationale and evidence. J Hypertens 16:S3–S9
4. Timmermans PB, Duncia JV, Carini DJ, Chiu AT, Wong PC, Wexler RR, Smith RD (1995) Discovery of losartan, the first angiotensin II receptor antagonist. J Hum Hypertens 9:S3–S18
5. Modlinger PS, Wilcox CS, Aslam S (2004) Nitric oxide, oxidative stress, and progression of chronic renal failure. Semin Nephrol 24:354–365
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献